Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0002111813-26-000010

President and CEO bought 2,806 shares at $19.76 ($55,447)

  • President and CEO acquired 53,465 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Parikh Anand Kiran · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-22 Purchase : show line 1 in the form +2,806 $19.76 $55,447 764,234 D
2026-06-22 Exercise or conversion : show line 2 in the form +45,252 $1.16 $52,492 809,486 D
2026-06-22 Exercise or conversion : show line 3 in the form +8,213 $1.16 $9,527 817,699 D
Open-market purchases · 2,806 sh · avg $19.76 · $55,447

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-22 Exercise or conversion : show line 4 in the form Employee Stock Option (right to buy) −45,252 91,632 D
2026-06-22 Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) −8,213 4,107 D
Loading xslF345X06/form4-06242026_100628.xml…